Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Citius Pharmaceuticals, Inc. (CTXR) had Free Cash Flow per Share of $-2.40 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.96M |
|
-- |
|
-- |
|
$8.44M |
|
$-8.44M |
|
$-0.04M |
|
$-8.48M |
|
$-8.48M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.44M |
|
$-8.38M |
|
11.07M |
|
11.07M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$27.93M |
|
-- |
|
$103.00M |
|
$130.94M |
|
$44.91M |
|
-- |
|
$8.50M |
|
$53.41M |
|
$77.53M |
|
$68.18M |
|
$77.53M |
|
18.07M |
|
| Cash Flow Statement Financials | |
$-26.55M |
|
$-5.75M |
|
$33.30M |
|
$3.25M |
|
$4.25M |
|
$1.00M |
|
$10.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.62 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.28% |
|
-12.82% |
|
-6.68% |
|
-11.28% |
|
$4.29 |
|
|
Free Cash Flow per Share |
$-2.40 |
$-2.40 |
|